VVT MedVVTMF 6 Shareholder Yield % is 1.33% as of Sep. 2025, which is 51% above its 10-year median of 0.88. GuruFocus rates VVTMF with a GF Score™ of 6/100. The stock has 4 warning signs investors should review. Among 819 Medical Devices & Instruments companies, VVT Med ranks better than 62.76% on this metric.
Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. It is a measure of shareholder return.
As of today, VVT Med's Shareholder Yield % was 1.33%.
VVT Med (OTCPK:VVTMF) Shareholder Yield % Explanation
Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. The term was coined by William W. Priest of Epoch Investment Partners in a paper in 2005 entitled The Case for Shareholder Yield as a Dominant Driver of Future Equity Returns. William Priest indicated that "shareholder yield is a term that we came up with to reflect the various ways dividends can be paid to owners of a business in a publicly-traded company."
Dividend Yield % shows how much a company pays out in dividends each year relative to its stock price, which is most obvious form of shareholder return.
Buyback Yield % is the net repurchase of shares outstanding over the market capital of the company. Shares repurchases also increase shareholder value by returning the money back to shareholders.
Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced.
VVT Med Shareholder Yield % Related Terms
VVT Med Shareholder Yield % Historical Data
* Premium members only.
The historical data trend for VVT Med's Shareholder Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
VVTMF vs ABT, SYK, MDT: Shareholder Yield % Comparison
For the Medical Devices subindustry, VVT Med's Shareholder Yield %, along with its competitors' market caps and Shareholder Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
VVT Med Shareholder Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, VVT Med's Shareholder Yield % distribution charts can be found below:
* The bar in red indicates where VVT Med's Shareholder Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Shareholder Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.
VVT Med (VVTMF) has a Shareholder Yield % of 1.33% as of Sep. 2025. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on VVT Med and its competitors. This is 51% above median its historical median of 0.88. Over the past decade, VVT Med's Shareholder Yield % has ranged from 0.88 to 1.33. According to the industry distribution chart, VVT Med ranks #305 out of 819 companies in the Medical Devices & Instruments industry, placing it in the top 37.2%.
Is VVT Med's Shareholder Yield % too high?
VVT Med's current Shareholder Yield % of 1.33% is 51% above median its 10-year median of 0.88. Over the past 10 years, this metric has ranged from a low of 0.88 to a high of 1.33. The Medical Devices & Instruments industry median Shareholder Yield % is 0.17. VVT Med's value of 1.33% is 682.4% above this industry median. Based on the distribution chart, VVT Med ranks #305 out of 819 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, VVT Med has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does VVT Med's Shareholder Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, VVT Med ranks #305 out of 819 companies for Shareholder Yield %. This puts VVT Med in the upper half of its industry. The industry median Shareholder Yield % is 0.17. VVT Med's value of 1.33% is 682.4% above this benchmark. Historically, VVT Med's own Shareholder Yield % has ranged from 0.88 to 1.33 over the past decade. While the company's 10-year median is 0.88 vs. the industry median of 0.17, VVT Med has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shareholder Yield % for a Medical Devices & Instruments company?
The median Shareholder Yield % among Medical Devices & Instruments companies is 0.17, based on 819 companies in the industry. Companies in the top quartile (top 25%) have a Shareholder Yield % significantly above this median, while those in the bottom quartile fall well below. However, Shareholder Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. VVT Med's current Shareholder Yield % of 1.33% is 682.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shareholder Yield % mean?
A high Shareholder Yield % can signal that a stock is expensive relative to its fundamentals. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on VVT Med and its competitors. For the Medical Devices & Instruments industry, the median Shareholder Yield % is 0.17 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. VVT Med's current Shareholder Yield % is 1.33%, which is 51% above median its own 10-year median of 0.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is VVT Med stock overvalued right now?
VVT Med (VVTMF) has a current Shareholder Yield % of 1.33%. The current Shareholder Yield % is 1.33%, which is 51% above median its 10-year median of 0.88 and 682.4% above the Medical Devices & Instruments industry median of 0.17. VVT Med's overall GF Score™ is 6/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shareholder Yield % calculated?
Shareholder Yield % is calculated from a company's financial statements. For VVT Med (VVTMF), the current Shareholder Yield % is 1.33% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
VVT Med Inc is a medical device company, focused on developing and commercializing a range of minimally invasive technologies for treating varicose veins. VVT's research and development activities are based in Israel. The company proudly boasts three products within its portfolio that have achieved commercial production status and are currently available in the market. These products have undergone meticulous design processes, obtaining regulatory approvals across multiple countries.
6GF Score
Get the complete analysis for VVTMF
Shareholder Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VVTMF has been successfully added to your 
